Detalhe da pesquisa
1.
Programmed Death Ligand-1 and Tumor Mutation Burden Testing of Patients With Lung Cancer for Selection of Immune Checkpoint Inhibitor Therapies: Guideline From the College of American Pathologists, Association for Molecular Pathology, International Association for the Study of Lung Cancer, Pulmonary Pathology Society, and LUNGevity Foundation.
Arch Pathol Lab Med
; 2024 Apr 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38625026